OBJECTIVES: Symptoms of gastroesophageal reflux disease (GERD) are the primary risk factor for Barrett's esophagus (BE). However, the significance of age at symptom onset is unknown. We examined the effects of multiple dimensions of GERD exposure on BE risk and whether these associations are modified by other risk factors for BE. METHODS: Data were from a cross-sectional study of 683 Veterans Affairs patients undergoing an elective esophagogastroduodenoscopy (EGD) or a study EGD concurrently with colonoscopy from primary care clinics. We compared 236 patients with both endoscopically suspected and histologically confirmed BE to 447 primary-care patients ("primary-care controls") without endoscopically suspected BE on their study EGD. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using multivariate logistic regression. RESULTS: Age at onset <30 years of frequent (at least weekly) GERD symptoms was associated with highest risk of BE (OR=15.1, 95% CI 7.91-28.8), and risk increased linearly with earlier age at onset of symptoms (P-trend=0.001). This association was independent of cumulative GERD symptom duration. People with early onset GERD symptoms who reported ever using proton pump inhibitors were at especially high risk of BE (OR=31.1, 95% CI 13.9-69.7). In people with frequent GERD symptoms, BE risk was almost 80% lower among Helicobacter pylori-positive patients (OR=2.60, 95% CI 1.26-5.40) than those negative for H. pylori (OR=8.24, 95% CI 5.00-13.6). CONCLUSIONS: Risk of BE increased linearly with earlier age at onset of frequent GERD symptoms. Age at symptom onset may help practitioners decide which patients with GERD symptoms to refer for endoscopic screening for BE.
OBJECTIVES: Symptoms of gastroesophageal reflux disease (GERD) are the primary risk factor for Barrett's esophagus (BE). However, the significance of age at symptom onset is unknown. We examined the effects of multiple dimensions of GERD exposure on BE risk and whether these associations are modified by other risk factors for BE. METHODS: Data were from a cross-sectional study of 683 Veterans Affairs patients undergoing an elective esophagogastroduodenoscopy (EGD) or a study EGD concurrently with colonoscopy from primary care clinics. We compared 236 patients with both endoscopically suspected and histologically confirmed BE to 447 primary-care patients ("primary-care controls") without endoscopically suspected BE on their study EGD. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using multivariate logistic regression. RESULTS: Age at onset <30 years of frequent (at least weekly) GERD symptoms was associated with highest risk of BE (OR=15.1, 95% CI 7.91-28.8), and risk increased linearly with earlier age at onset of symptoms (P-trend=0.001). This association was independent of cumulative GERD symptom duration. People with early onset GERD symptoms who reported ever using proton pump inhibitors were at especially high risk of BE (OR=31.1, 95% CI 13.9-69.7). In people with frequent GERD symptoms, BE risk was almost 80% lower among Helicobacter pylori-positive patients (OR=2.60, 95% CI 1.26-5.40) than those negative for H. pylori (OR=8.24, 95% CI 5.00-13.6). CONCLUSIONS: Risk of BE increased linearly with earlier age at onset of frequent GERD symptoms. Age at symptom onset may help practitioners decide which patients with GERD symptoms to refer for endoscopic screening for BE.
Authors: Jennifer R Kramer; Lori A Fischbach; Peter Richardson; Abeer Alsarraj; Stephanie Fitzgerald; Yasser Shaib; Neena S Abraham; Maria Velez; Rhonda Cole; Bhupinderjit Anand; Gordana Verstovsek; Massimo Rugge; Paola Parente; David Y Graham; Hashem B El-Serag Journal: Clin Gastroenterol Hepatol Date: 2012-12-04 Impact factor: 11.382
Authors: C Winters; T J Spurling; S J Chobanian; D J Curtis; R L Esposito; J F Hacker; D A Johnson; D F Cruess; J D Cotelingam; M S Gurney Journal: Gastroenterology Date: 1987-01 Impact factor: 22.682
Authors: Douglas K Rex; Oscar W Cummings; Michael Shaw; Mark D Cumings; Roy K H Wong; Raj S Vasudeva; Donal Dunne; Emad Y Rahmani; Debra J Helper Journal: Gastroenterology Date: 2003-12 Impact factor: 22.682
Authors: William D Hazelton; Kit Curtius; John M Inadomi; Thomas L Vaughan; Rafael Meza; Joel H Rubenstein; Chin Hur; E Georg Luebeck Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-04-30 Impact factor: 4.254
Authors: Jing Dong; Puya Gharahkhani; Wong-Ho Chow; Marilie D Gammon; Geoffrey Liu; Carlos Caldas; Anna H Wu; Weimin Ye; Lynn Onstad; Lesley A Anderson; Leslie Bernstein; Paul D Pharoah; Harvey A Risch; Douglas A Corley; Rebecca C Fitzgerald; Prasad G Iyer; Brian J Reid; Jesper Lagergren; Nicholas J Shaheen; Thomas L Vaughan; Stuart MacGregor; Sharon Love; Claire Palles; Ian Tomlinson; Ines Gockel; Andrea May; Christian Gerges; Mario Anders; Anne C Böhmer; Jessica Becker; Nicole Kreuser; Rene Thieme; Tania Noder; Marino Venerito; Lothar Veits; Thomas Schmidt; Claudia Schmidt; Jakob R Izbicki; Arnulf H Hölscher; Hauke Lang; Dietmar Lorenz; Brigitte Schumacher; Rupert Mayershofer; Yogesh Vashist; Katja Ott; Michael Vieth; Josef Weismüller; Markus M Nöthen; Susanne Moebus; Michael Knapp; Wilbert H M Peters; Horst Neuhaus; Thomas Rösch; Christian Ell; Janusz Jankowski; Johannes Schumacher; Rachel E Neale; David C Whiteman; Aaron P Thrift Journal: Clin Gastroenterol Hepatol Date: 2019-02-01 Impact factor: 11.382
Authors: Xiangqing Sun; Robert C Elston; Jill S Barnholtz-Sloan; Gary W Falk; William M Grady; Ashley Faulx; Sumeet K Mittal; Marcia Canto; Nicholas J Shaheen; Jean S Wang; Prasad G Iyer; Julian A Abrams; Ye D Tian; Joseph E Willis; Kishore Guda; Sanford D Markowitz; Apoorva Chandar; James M Warfe; Wendy Brock; Amitabh Chak Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-02-29 Impact factor: 4.254